Richards, Merrill & Peterson, Inc. Abb Vie Inc. Transaction History
Richards, Merrill & Peterson, Inc.
- $192 Billion
- Q1 2025
A detailed history of Richards, Merrill & Peterson, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Richards, Merrill & Peterson, Inc. holds 4,996 shares of ABBV stock, worth $926,658. This represents 0.54% of its overall portfolio holdings.
Number of Shares
4,996
Previous 4,974
0.44%
Holding current value
$926,658
Previous $884 Million
18.42%
% of portfolio
0.54%
Previous 0.46%
Shares
2 transactions
Others Institutions Holding ABBV
# of Institutions
4,269Shares Held
1.27BCall Options Held
18.2MPut Options Held
15.5M-
Vanguard Group Inc Valley Forge, PA174MShares$32.3 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.3 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$14.8 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.2 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.63 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $328B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...